Research Scientist, Fibrosis Biology

Foster City, CA
Jun 26, 2022
Required Education
Position Type
Full time

Specific Responsibilities:

Gilead seeks a highly motivated and collaborative scientist to drive research efforts to discover and develop novel therapies for the treatment of inflammatory and fibrotic diseases, including fibrotic liver (NASH, PSC) and lung (IPF/ILD) and autoimmune (RA, lupus) diseases. The successful candidate will support discovery and translational research activities aimed at characterizing novel therapeutic targets and advancing discovery programs to the clinic. The role is within an established group focused on fibrotic, metabolic and inflammatory diseases and will interface with multidisciplinary project teams. This position provides an exciting opportunity to have high impact on the growth of a therapeutic area within an established research group focused on developing drugs for diseases with serious, unmet medical needs.

Essential Duties and Responsibilities:

The successful candidate will work in a project team-based research structure to lead or support biological investigations of new and established projects. Responsibilities include:
  • Independently design, conduct and analyze experiments to support the initiation and/or advancement of drug candidates.
  • Design, execute and analyze key in vivo pharmacology experiments to validate potential therapeutic targets, and lead early research to advance biology of novel targets/pathways
  • Successful candidate must be able to manage multiple projects at any given time, and work in a fast-paced, cross-functional and highly collaborative team environment.
  • Presents research findings and recommendations to senior staff, prepare research reports and peer-reviewed manuscripts, and contribute to the preparation of INDs, and patent filings.
  • May manage and train Research Associates in design, initiation, and execution of laboratory experimentation with a "lead from the bench" approach:
  • Work closely with academic collaborators and outside entities to advance research needs
  • Demonstrates strong communication skills (both verbal and written) and interpersonal skills to communicate ideas, objectives and results.

Knowledge, Experience and Skills:
  • PhD with 0-2+ years of industry experience and track record of success in academia
  • Must have In vivo pharmacology experience with small rodents (mice and/or rat) experience with different routes of dosing (e.g. PO, SC, TV, IP), necropsy, tissue collection, non-invasive biofluid collection) and survival surgery (preferred).
  • Experience performing multi-color FACS/Flow Cytometry from tissue and circulation required
  • Experience in immunology, autoimmunity, inflammatory disease research required.
  • Understanding of Fibrosis mechanisms and research preferred
  • Experience with modern molecular biology techniques (e.g. ELISA, qPCR) ideal
  • Prior experience in single-cell and single-nuclear RNA-Seq is a plus
  • Strong analytical and computer skills are required, including proficiency with basic data analysis programs (Excel, GraphPad Prism) and application of statistics.

For jobs in the United States:

As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact for assistance.

Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Gilead has made the decision to require all U.S. employees and contractors to receive the COVID-19 vaccines as a condition of employment. "Full vaccination" is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation.​

For more information about equal employment opportunity protections, please view the ‘EEO is the Law' poster.



Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.